The presence of Helicobacter pylori in the liver depends on the Th1, Th17 and Treg cytokine profile of the patient

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue 6, 2011, Pages 748-754

  Silva, Luciana Diniz ^a   Rocha, Andreia Maria Camargos ^a   Rocha, Gifone Aguiar ^a   de Moura, Sílvia Beleza ^b   Rocha, Márcia Maria Negreiros Pinto ^a   Dani, Renato ^c   de Melo, Fabrício Freire ^a,b   Guerra, Juliana Becattini ^a   de Castro, Lúcia Porto Fonseca ^a   Mendes, Guilherme Santiago ^c   de Abreu Ferrari, Teresa Cristina ^a   Lima, Agnaldo Soares ^a   Queiroz, Dulciene Maria Magalhães ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Hospital Governador Israel Pinheiro   (Brazil)

Author keywords

Helicobacter pylori; IFN ; IL 10; IL 17; Liver diseases

Indexed keywords

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 80053993405     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000600016     Document Type: Article

References (22)

1. Algood HM, Cover TL 2006. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev 19: 597-613.
2. Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac-Sage P, Balabaud C, Mégraud F 2000. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 89: 1431-1439.
3. Caruso R, Pallone F, Monteleone G 2007. Emerging role of IL-23/IL-17 axis in H. pylori-associated pathology. World J Gastroenterol 13: 5547-5551.
4. D'Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G 1997. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158: 962-967.
5. Dore MP, Realdi G, Mura D, Graham DY, Sepúlveda AR 2002. Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis and hepatocellular carcinoma. Dig Dis Sci 47: 1638-1643.
6. Fainboim L, Chernavsky A, Paladino N, Flores AC, Arruvito L 2007. Cytokines and chronic liver disease. Cytokine Growth Factor Rev 18: 143-157.
7. Fan XG, Peng XN, Huang Y, Yakoob J, Wang ZM, Chen YP 2002. Helicobacter species ribosomal DNA recovered from the liver tissue of Chinese patients with primary hepatocellular carcinoma. Clin Infect Dis 35: 1555-1557.
8. Lafdil F, Miller AM, Ki SH, Gao B 2010. Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol 22: 1-5.
9. Lemmers A, Moreno C, Gustot T, Maréchal R, Degré D, Demetter P, Nadai P, Geerts A, Quertinmont E, Vercruysse V, Le Moine O, Devière J 2009. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49: 646-657.
10. Marzio L, Angelucci D, Grossi L, Diodoro MG, Campli ED, Cellini L 1998. Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy. Am J Gastroenterol 93: 223-226.
11. Moura SB, Almeida LR, Guerra JB, Rocha GA, Rocha AMC, Melo FF, Corrêa-Oliveira R, Bittencourt P, Carvalho SD, Queiroz DMM 2008. Toll-like receptor (TLR2, TLR4 and TLR5) gene polymorphisms and Helicobacter pylori infection in children with and without duodenal ulcer. Microbes infect 10: 1477-1483.
12. Oliveira AG, Rocha GA, Rocha AM, Sanna MG, Moura SB, Dani R, Marinho FP, Moreira LS, Ferrari ML, Castro LP, Queiroz DMM 2006. Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease. Helicobacter 11: 2-9.
13. Pellicano R, Ménard A, Rizzetto M, Mégraud F 2008. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 8: 254-260.
14. Queiroz DMM, Santos A, Oliveira AG, Rocha GA, Moura SB, Camargo ERS, Valle PR, Bicalho LAF, Dani R 2001. Isolation of a Helicobacter strain from the human liver. Gastroenterology 121: 1023-1024 (erratum in Gastroenterology 122: 250, 2002).
15. Rocha GA, Oliveira AM, Queiroz DMM, Mendes EN, Moura SB, Oliveira CA, Ferrari TCA 1998. Serodiagnosis of Helicobacter pylori infection by Cobas Core ELISA in adults from Minas Gerais, Brazil. Braz J Med Biol Res 31: 1263-1268.
16. Rocha M, Avenaud P, Ménard A, Le Bail B, Balabaud C, Bioulac-Sage P, Queiroz DMM, Mégraud F 2005. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 54: 396-401.
17. Sherlock S, Dooley J 2002. Malignant liver tumors. In S Sherlock, J Dooley, Diseases of thse liver and biliary system, Blackwell, London, p. 537-554.
18. Straubinger RK, Greiter A, McDonough SP, Gerold A, Scanziani E, Soldati S, Dailidiene D, Dailide G, Berg DE, Simpson KW 2003. Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect Immun 71: 2693-2703.
19. Verhoef C, Pot RG, de Man RA, Zondervan PE, Kuipers EJ, IJzermans JN, Kusters JG 2003. Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients hepatocellular carcinoma. Eur J Gastroenterol Hepatol 15: 1171-1174.
20. Wang JT, Lin JT, Sheu JC, Yang JC, Chen DS, Wang TH 1993. Detection of Helicobacter pylori in gastric biopsy tissue by polymerase chain reaction. Eur J Clin Microbiol Infect Dis 12: 367-371.
21. Wong CK, Lit LCW, Tam LS, Li EKM, Wong PTY, Lam CWK 2008. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 127: 385-393.
22. Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, Fu JL, Shi F, Shi M, Wang HF 2010. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51: 81-91.